Home › Therapeutic areas › Other respiratory agents
Japan market screening · Therapeutic class
その他の呼吸器官用剤 · Japan Standard Commodity Classification
19 molecules in this class are marketed in Japan across 89 products. 2 of those products are not shipping normally today — 2.2% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.
Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.
| Molecule | Products | Companies | Constrained | Supply mix |
|---|---|---|---|---|
| Fluticasone Propionateフルチカゾンプロピオン酸エステル | 18 | 8 | — | |
| Budesonideブデソニド | 10 | 5 | 2 | |
| Salmeterol Xinafoate / Fluticasone Propionateサルメテロールキシナホ酸塩・フルチカゾンプロピオン酸エステル | 9 | 1 | — | |
| Budesonide / Formoterol Fumarate Hydrateブデソニド・ホルモテロールフマル酸塩水和物 | 8 | 4 | — | |
| Omalizumab (Genetical Recombination)オマリズマブ（遺伝子組換え） | 6 | 1 | — | |
| Vilanterol Trifenatate / Fluticasone Furoateビランテロールトリフェニル酢酸塩・フルチカゾンフランカルボン酸エステル | 6 | 1 | — | |
| Ciclesonideシクレソニド | 4 | 1 | — | |
| Fluticasone Furoate / Umeclidinium Bromide / Vilanterol Trifenatateフルチカゾンフランカルボン酸エステル・ウメクリジニウム臭化物・ビランテロールトリフェニル酢酸塩 | 4 | 1 | — | |
| Fluticasone Propionate / Formoterol Fumarate Hydrateフルチカゾンプロピオン酸エステル・ホルモテロールフマル酸塩水和物 | 4 | 1 | — | |
| Benralizumab (Genetical Recombination)ベンラリズマブ（遺伝子組換え） | 3 | 1 | — | |
| Indacaterol Acetate / Mometasone Furoateインダカテロール酢酸塩・モメタゾンフランカルボン酸エステル | 3 | 1 | — | |
| Mepolizumab (Genetical Recombination)メポリズマブ（遺伝子組換え） | 3 | 1 | — | |
| Budesonide / Glycopyrronium Bromide / Formoterol Fumarate Hydrateブデソニド・グリコピロニウム臭化物・ホルモテロールフマル酸塩水和物 | 2 | 1 | — | |
| Depemokimab (Genetical Recombination)デペモキマブ（遺伝子組換え） | 2 | 1 | — | |
| Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoateインダカテロール酢酸塩・グリコピロニウム臭化物・モメタゾンフランカルボン酸エステル | 2 | 1 | — | |
| Tezepelumab (Genetical Recombination)テゼペルマブ（遺伝子組換え） | 2 | 1 | — | |
| Dornase Alfa (Genetical Recombination)ドルナーゼ アルファ（遺伝子組換え） | 1 | 1 | — | |
| Gefapixant Citrateゲーファピキサントクエン酸塩 | 1 | 1 | — | |
| Sargramostim (Genetical Recombination)サルグラモスチム（遺伝子組換え） | 1 | 1 | — |
Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.
Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.
Send an enquiryOur Database Division replies in English within three business days (Japan time).